These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31334885)

  • 21. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
    Park CH; Kim EH; Roh YH; Kim HY; Lee SK
    PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
    Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
    Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies.
    Wu X; Zhang D; Yu Y; Lou L; Li X
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32406491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
    Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
    PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
    Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
    Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
    Shi D; Zhou Z; Dai Y; Pan X; Cao Q
    Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Proton Pump Inhibitor Use With Serum Biomarkers of Inflammation, Insulin Resistance, Cardiovascular Risk, and Renal Function.
    Austin GL; Weiskopf JR; Czwornog JL
    J Clin Gastroenterol; 2018 Sep; 52(8):691-695. PubMed ID: 29099466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
    Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
    World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
    Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
    [No Abstract]   [Full Text] [Related]  

  • 32. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    Drug Saf; 2018 Dec; 41(12):1387-1396. PubMed ID: 30146658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.
    Sun S; Cui Z; Zhou M; Li R; Li H; Zhang S; Ba Y; Cheng G
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27577963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Association Linking Short-Term Proton Pump Inhibitor Use to Dementia: Systematic Review and Meta-analysis of Observational Studies.
    Khan MA; Yuan Y; Iqbal U; Kamal S; Khan M; Khan Z; Lee WM; Howden CW
    Am J Gastroenterol; 2020 May; 115(5):671-678. PubMed ID: 31895707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies.
    Pan S; Thrift AP; Akhdar G; El-Serag HB
    Dig Dis Sci; 2023 Sep; 68(9):3732-3744. PubMed ID: 37432532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis.
    Choudhury A; Jena A; Jearth V; Dutta AK; Makharia G; Dutta U; Goenka M; Kochhar R; Sharma V
    Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):479-487. PubMed ID: 37060552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton-Pump Inhibitors and Risk of Dementia.
    Ford RL; Swanson KA
    Consult Pharm; 2017 Nov; 32(11):682-686. PubMed ID: 29113635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
    J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis.
    Guo H; Zhang R; Zhang P; Chen Z; Hua Y; Huang X; Li X
    Front Pharmacol; 2023; 14():1129948. PubMed ID: 37007006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.